Published On: Wed, Oct 19th, 2016

Current Price Targets For Intuitive Surgical, Inc. (NASDAQ:ISRG)


Recently stock market analysts have updated their consensus ratings on shares of Intuitive Surgical, Inc. (NASDAQ:ISRG).

Most recent broker ratings

10/13/2016 – Wells Fargo began new coverage on Intuitive Surgical, Inc. giving the company a “outperform” rating.

09/19/2016 – Intuitive Surgical, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 780 price target on the stock.

08/26/2016 – Raymond James began new coverage on Intuitive Surgical, Inc. giving the company a “outperform” rating.

07/21/2016 – Intuitive Surgical, Inc. was downgraded to “under perform” by analysts at Northland Securities. They now have a USD 600 price target on the stock.

07/20/2016 – Intuitive Surgical, Inc. had its “buy” rating reiterated by analysts at Citigroup. They now have a USD 779 price target on the stock.

07/20/2016 – Intuitive Surgical, Inc. had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 775 price target on the stock.

07/20/2016 – Intuitive Surgical, Inc. had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 750 price target on the stock.

07/20/2016 – Intuitive Surgical, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 750 price target on the stock.

07/20/2016 – Intuitive Surgical, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 800 price target on the stock.

07/20/2016 – Intuitive Surgical, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 700 price target on the stock.

07/20/2016 – Intuitive Surgical, Inc. had its “neutral” rating reiterated by analysts at BTIG Research.

07/20/2016 – Intuitive Surgical, Inc. had its “outperform” rating reiterated by analysts at Wedbush. They now have a USD 755 price target on the stock.

06/02/2016 – Intuitive Surgical, Inc. was downgraded to “neutral” by analysts at Goldman Sachs. They now have a USD 674 price target on the stock.

04/20/2016 – Intuitive Surgical, Inc. had its “sector perform” rating reiterated by analysts at RBC Capital. They now have a USD 640 price target on the stock.

04/20/2016 – Intuitive Surgical, Inc. had its “buy” rating reiterated by analysts at Bank of America Merrill Lynch. They now have a USD 750 price target on the stock.

Intuitive Surgical, Inc. has a 50 day moving average of 703.09 and a 200 day moving average of 666.36. The stock’s market capitalization is 27.78B, it has a 52-week low of 483.11 and a 52-week high of 727.25.

The share price of the company (NASDAQ:ISRG) was up +1.73% during the last trading session, with a high of 723.31 and the volume of Intuitive Surgical, Inc. shares traded was 518327.

Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company’s instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.